MedPath

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

Conditions
Non-small Cell Lung Cancer
Registration Number
NCT02202655
Lead Sponsor
Beijing Chao Yang Hospital
Brief Summary

The purpose of this study is to investigate the changes of lymphocyte subsets in chemotherapy course of patients with non-small cell lung cancer

Detailed Description

patients with primary non-small cell lung cancer who received first chemotherapy in Beijing Chaoyang Hospital affiliated to Capital Medical University were collected, and the percentage of lymphocyte subsets at 9 time points before, during, and after chemotherapy was detected by flow cytometry method.We will investigate the changes of patients' lymphocyte subsets in chemotherapy courses. The correlation of the percentage of lymphocyte subsets and age, gender, pathological type, clinical stage, surgery or not, clinical efficacy assessment will be further analyzed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Each Period Non-small Cell Lung Cancer, Which Was Confirmed by Histopathology. patients has only lung cancer .
  • Functional Status Score (PS) ≧ 70.
  • The first time for chemotherapy .
  • A Written Informed Consent.
Exclusion Criteria
  • Merging other tumors.
  • HAve autoimmune diseases.
  • AIDS

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the changes of patients' lymphocyte subsets in chemotherapy courses.up to cycle 4 day 9
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

WangQian

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath